Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
AURA•Second-quarter results and business highlights
Aug. 11 (Reuters) - Aura Biosciences, Inc. AURA.O:
- Aura Biosciences reports second quarter 2026 financial results and recent business highlights
- Aura Biosciences - Phase 3 COMPASS trial fully enrolled with 108 patients; topline data expected in 2H 2027
- Aura Biosciences - Organizational restructuring and capital allocation extend cash runway into 1H 2029
- Aura Biosciences - Reduces workforce by about 20% to focus on ocular oncology
